These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9703014)

  • 1. Fever and rash after amifostine therapy.
    Buresh CM; Baker KS; Shafer M
    J Pediatr Hematol Oncol; 1998; 20(4):361-2. PubMed ID: 9703014
    [No Abstract]   [Full Text] [Related]  

  • 2. Amifostine-related fever-rash during fractionated radiotherapy: diagnostic and predictive role of C-reactive protein.
    Koukourakis MI; Pitsiava D; Giatromanolaki A; Kambouromiti G; Sivridis E; Kartalis G
    Am J Clin Oncol; 2011 Jun; 34(3):281-5. PubMed ID: 20838325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic inflammatory response syndrome associated with amifostine.
    Shaw PJ; Bleakley M
    Med Pediatr Oncol; 2000 Apr; 34(4):309-10. PubMed ID: 10742082
    [No Abstract]   [Full Text] [Related]  

  • 4. Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia.
    Erikci AA; Ozturk A; Karagoz B; Bilgi O; Turken O; Top C; Kandemir EG
    Hematology; 2008 Oct; 13(5):289-92. PubMed ID: 18854092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stimulation by amifostine and sodium phenylbutyrate: what is the potential in MDS?
    List AF
    Leuk Res; 1998 May; 22 Suppl 1():S7-11. PubMed ID: 9734693
    [No Abstract]   [Full Text] [Related]  

  • 6. Fever, rash, and angioedema after a course of allopurinol.
    Yale SH; Yale ES; Mann DS
    Hosp Pract (1995); 1996 Mar; 31(3):92-4. PubMed ID: 8596012
    [No Abstract]   [Full Text] [Related]  

  • 7. A rash during surgery: rounding up the usual suspects.
    Cuervo-Pardo L; Gonzalez-Estrada A; Fernandez J; Pien LC
    BMJ Case Rep; 2015 Mar; 2015():. PubMed ID: 25824288
    [No Abstract]   [Full Text] [Related]  

  • 8. Amifostine in combination with erythropoietin and G-CSF promotes multilineage hematopoiesis in patients with myelodysplastic syndrome.
    Neumeister P; Jaeger G; Eibl M; Sormann S; Zinke W; Linkesch W
    Leuk Lymphoma; 2001 Jan; 40(3-4):345-9. PubMed ID: 11426556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rash and fever in a man with granulomatosis with polyangiitis (Wegener's).
    Willis DF; Chacko B
    Nephrology (Carlton); 2016 Sep; 21(9):792. PubMed ID: 27546779
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful management of acute myeloid leukemia transformed from myelodysplastic syndromes in an elderly patient aged over 80 years old by ultralow dose decitabine combined with amifostine and autologous CIK cells.
    Yang B; Wang HT; Cai LL; Zhao Y; Chi XH; Zhu HL; Ran HH; Yang Y; Yu RL; Li SW; Lu XC
    Ann Hematol; 2014 Jul; 93(7):1233-5. PubMed ID: 24240975
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP).
    Boccia R; Anné PR; Bourhis J; Brizel D; Daly C; Holloway N; Hymes S; Koukourakis M; Kozloff M; Turner M; Wasserman T
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):302-9. PubMed ID: 15337569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dermatologic reactions to amifostine].
    Moreno Alvarez PJ; Madurga Sanz M
    Farm Hosp; 2003; 27(3):200-1. PubMed ID: 12835824
    [No Abstract]   [Full Text] [Related]  

  • 13. Serious cutaneous reactions to amifostine.
    Prescrire Int; 2003 Dec; 12(68):225. PubMed ID: 14986696
    [No Abstract]   [Full Text] [Related]  

  • 14. Poor response rate to a continuous schedule of Amifostine therapy for 'low/intermediate risk' myelodysplastic patients.
    Bowen DT; Denzlinger C; Brugger W; Culligan D; Gelly K; Adlakha S; Groves M; Hepburn M; Kanz L
    Br J Haematol; 1998 Dec; 103(3):785-7. PubMed ID: 9858231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strategy of 'treating through' a prasugrel-induced rash.
    Yang DC; Feldman DN; Kim LK; Minutello RM; Bergman G; Wong SC; Swaminathan RV
    Int J Cardiol; 2013 Oct; 168(4):4381-2. PubMed ID: 23706323
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved hematopoiesis using amifostine in secondary myelodysplasia.
    Auletta JJ; Shurin S
    J Pediatr Hematol Oncol; 1999; 21(6):531-4. PubMed ID: 10598667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amifostine in the treatment of patients with myelodysplastic syndrome.
    Larsen SR; Manoharan A
    Aust N Z J Med; 1999 Oct; 29(5):753-4. PubMed ID: 10630666
    [No Abstract]   [Full Text] [Related]  

  • 18. Amifostine as differentiating agent in cord blood and bone marrow cultures from children with hematological disorders.
    Danilatou V; Dimitriou H; Stiakaki E; Kalmanti M
    Pediatr Hematol Oncol; 2004 Mar; 21(2):125-34. PubMed ID: 15160511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of Stevens-Johnson syndrome: toxic epidermal necrolysis possibly induced by amifostine during radiotherapy.
    Lale Atahan I; Ozyar E; Sahin S; Yildiz F; Yalçin B; Karaduman A
    Br J Dermatol; 2000 Nov; 143(5):1072-3. PubMed ID: 11069524
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxcarbazepine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
    D'Orazio JL
    Clin Toxicol (Phila); 2008 Dec; 46(10):1093-4. PubMed ID: 18821094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.